The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors

被引:372
作者
Bruchas, M. R. [1 ]
Land, B. B. [1 ,2 ]
Chavkin, C. [1 ,2 ]
机构
[1] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
[2] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA
关键词
Dynorphin; Kappa opioid receptor; Corticotropin-releasing factor; Corticotropin-releasing hormone; Addiction; Stress; Reward; Anxiety; Dysphoria; Aversion; Cocaine; p38 Mitogen-activated protein kinase; Extracellular signal-regulated kinase; Urocortin; Reinstatement; Preference; Drug abuse; Relapse; CORTICOTROPIN-RELEASING-FACTOR; ELEMENT-BINDING PROTEIN; CONDITIONED PLACE PREFERENCE; KAPPA-OPIATE RECEPTORS; FORCED SWIM TEST; COCAINE-SEEKING; INDUCED RELAPSE; INDUCED REINSTATEMENT; SEROTONIN EFFLUX; INDUCED ANTINOCICEPTION;
D O I
10.1016/j.brainres.2009.08.062
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Stress is a complex experience that carries both aversive and motivating properties. Chronic stress causes an increase in the risk of depression, is well known to increase relapse of drug seeking behavior, and can adversely impact health. Several brain systems have been demonstrated to be critical in mediating the negative affect associated with stress, and recent evidence directly links the actions of the endogenous opioid neuropeptide dynorphin in modulating mood and increasing the rewarding effects of abused drugs. These results suggest that activation of the dynorphin/kappa opioid receptor (KOR) system is likely to play a major role in the pro-addictive effects of stress. This review explores the relationship between dynorphin and corticotropin-releasing factor (CRF) in the induction of dysphoria, the potentiation of drug seeking, and stress-induced reinstatement. We also provide an overview of the signal transduction events responsible for CRF and dynorphin/KOR-dependent behaviors. Understanding the recent work linking activation of CRF and dynorphin/KOR systems and their specific roles in brain stress systems and behavioral models of addiction provides novel insight to neuropeptide systems that regulate affective state. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:44 / 55
页数:12
相关论文
共 125 条
  • [1] Role of lateral hypothalamic orexin neurons in reward processing and addiction
    Aston-Jones, Gary
    Smith, Rachel J.
    Moorman, David E.
    Richardson, Kimberlei A.
    [J]. NEUROPHARMACOLOGY, 2009, 56 : 112 - 121
  • [2] Sensitivity to stress: Dysregulation of CRF pathways and disease development
    Bale, TL
    [J]. HORMONES AND BEHAVIOR, 2005, 48 (01) : 1 - 10
  • [3] CRF and CRF receptors: Role in stress responsivity and other behaviors
    Bale, TL
    Vale, WW
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 : 525 - 557
  • [4] BALSKUBIK R, 1993, J PHARMACOL EXP THER, V264, P489
  • [5] Changes in hippocampal circuitry after pilocarpine-induced seizures as revealed by opioid receptor distribution and activation
    Bausch, SB
    Chavkin, C
    [J]. JOURNAL OF NEUROSCIENCE, 1997, 17 (01) : 477 - 492
  • [6] Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats
    Beardsley, PM
    Howard, JL
    Shelton, KL
    Carroll, FI
    [J]. PSYCHOPHARMACOLOGY, 2005, 183 (01) : 118 - 126
  • [7] Belcheva MM, 1998, J NEUROCHEM, V70, P635
  • [8] μ and κ opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes
    Belcheva, MM
    Clark, AL
    Haas, PD
    Serna, JS
    Hahn, JW
    Kiss, A
    Coscia, CJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (30) : 27662 - 27669
  • [9] Control of hormonal stress reactivity by the endogenous opioid system
    Bilkei-Gorzo, Andras
    Racz, Ildiko
    Michel, Kerstin
    Mauer, Daniela
    Zimmer, Anne
    Klingmueller, Dietrich
    Zimmer, Andreas
    [J]. PSYCHONEUROENDOCRINOLOGY, 2008, 33 (04) : 425 - 436
  • [10] The role of CREB in depression and antidepressant treatment
    Blendy, JA
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (12) : 1144 - 1150